Opioids and adverse outcomes in elderly chronic obstructive pulmonary disease patients

Damien Viglino, Maxime Maignan

Source: Eur Respir J 2016; 48: 1817
Journal Issue: December

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Damien Viglino, Maxime Maignan. Opioids and adverse outcomes in elderly chronic obstructive pulmonary disease patients. Eur Respir J 2016; 48: 1817

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Roflumilast in severely ill patients with chronic obstructive pulmonary disease with frequent exacerbations: real-life outcomes
Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD
Year: 2020


Cardiovascular comorbidities in chronic obstructive pulmonary disease patients
Source: International Congress 2017 – COPD biomarkers
Year: 2017

Hyperglycemia is associated with poor outcomes in patients with acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013

Cardiovascular comorbidity and mortality in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD epidemiology
Year: 2012


Frequency of adverse consequences after spirography in patients with chronic obstructive pulmonary disease and concomitant ischemic heart disease
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016

Psychological outcomes from pulmonary rehabilitation in patients with chronic obstructive lung disease
Source: Annual Congress 2010 - The psychological impact and educational issues of chronic lung disease: could we do more?
Year: 2010

Cardiac biomarkers and outcome in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD exacerbation
Year: 2012


Readmission predictors in patients with chronic obstructive pulmonary disease hospitalized for an exacerbation
Source: Annual Congress 2011 - Exacerbations and severe chronic respiratory disease: oxygen, rehabilitation, admission to hospital and palliative care
Year: 2011


Real-life experience of older patients requiring NIV for exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2009 - New trends in noninvasive ventilation for acute respiratory failure
Year: 2009

Hospitalization burden in chronic obstructive pulmonary disease patients after pulmonary rehabilitation
Source: Annual Congress 2003 - Outcome of integrated care on burden of chronic respiratory failure
Year: 2003


A study of hematologic disorders in patients with chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Year: 2020


Mortality in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 210s
Year: 2001

Hyperglycaemia and its association with outcomes in people admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 332s
Year: 2006

Proactive integrated care improves quality of life in patients with COPD
Source: Eur Respir J 2009; 33: 1031-1038
Year: 2009



The efficacy and side-effects of varenicline in patients with mild to moderate chronic obstructive pulmonary diseases
Source: Annual Congress 2010 - Passive smoking
Year: 2010


Acute exacerbations of chronic obstructive pulmonary disease: Impact of cardiovascular co-morbidities
Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD
Year: 2010


Bronchiectasis impact outcomes in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008


Factors affecting in-hospital mortality in patients with chronic obstructive pulmonary disease exacerbation
Source: Annual Congress 2013 –The latest insights in chronic care
Year: 2013

Can we predict the outcomes of treatment of patients with severe exacerbation of chronic obstructive pulmonary disease (COPD)?
Source: Eur Respir J 2001; 18: Suppl. 33, 241s
Year: 2001

Doxycycline for exacerbations of chronic obstructive pulmonary disease in outpatients: who benefits?
Source: ERJ Open Res, 6 (2) 00099-2020; 10.1183/23120541.00099-2020
Year: 2020